MH Katz, JL Gerberding - New England Journal of Medicine, 1997 - content.nejm.org Among health care workers who have occupational exposures to the human
immunodeficiency virus (HIV), a recent case–control study indicates that
treatment with zidovudine after exposure decreases the odds of HIV ... Cited by 169 - Related articles - BL Direct - All 6 versions
- ►annals.org KA Sepkowitz - Annals of Internal Medicine, 1996 - Am Coll Physicians Background: Health care workers are at occupational risk for a vast array of
infections that cause substantial illness and occasional deaths. Despite this,
few studies have examined the incidence, prevalence, or exposure-associated ... Cited by 136 - Related articles - BL Direct - All 7 versions
MH Katz, JL Gerberding - Annals of internal medicine, 1998 - Am Coll Physicians Until recently, patients had little motivation to seek medical care soon after
sexual exposure to HIV.However, evidence that antiretroviral treatment prevents
HIV infection after occupational exposure has led to the recommendation ... Cited by 98 - Related articles - BL Direct - All 6 versions
J James, A Carruthers, J Carruthers - Dermatologic Surgery, 2002 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 84 - Related articles - All 4 versions
JD Bamberger, CR Waldo, JL Gerberding, MH … - The American journal of medicine, 1999 - Elsevier Although the 1998 Centers for Disease Control and Prevention's guidelines for
treatment of sexually transmitted diseases recommend offering postexposure
prophylaxis for human immunodeficiency virus (HIV) infection following ... Cited by 77 - Related articles - BL Direct - All 11 versions
SD Pinkerton, DR Holtgrave, FR Bloom - Aids, 1998 - journals.lww.com HIV-infected or suspect blood, the US PHS recom- mends prophylaxis consisting of
a 4-week regimen of triple combination therapy with two reverse transcrip- tase
inhibitors, zidovudine (ZDV) and lamivudine (3TC), and the protease ... Cited by 77 - Related articles - BL Direct - All 3 versions
DL Gentle, ML Stoller, TW Jarrett, JF Ward, … - Urology, 1997 - Elsevier Indinavir therapy averaged 5.7 months prior to presentation with renal colic.
All patients had microscopic hematuria. One patient presented with acute
azotemia from bilateral urinary obstruction. Six patients had no history of ... Cited by 62 - Related articles - BL Direct - All 7 versions
DK Henderson - JAMA, 1999 - Am Med Assoc Sobered by the occurrence of an occupational HIV infection in a health care
worker at the Warren G. Magnuson Clinical Center of the National Institutes of
Health, Bethesda, Md, in 1988, our institution began offering postexposure ... Cited by 50 - Related articles - BL Direct - All 6 versions
- ►annals.org GC Mejicano, DG Maki - Annals of internal medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To estimate the risk for acquiring an infectious disease during ... Cited by 52 - Related articles - BL Direct - All 5 versions
WJ REITER, H SCHON-PERNERSTORFER, … - The Journal of urology, 1999 - Elsevier Indinavir was approved by the Food and Drug Administration in 1996 as a human
immunodeficiency type 1 protease inhibitor to treat human immunodeficiency virus
infection. Prompted by the high number of patients receiving indinavir who ... Cited by 49 - Related articles - BL Direct - All 8 versions
